Glenmede Trust’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAT
ACH
AAM
GL
SGCM
PCM
Glenmede Trust's BEAT Position: Q4 2020 in Review
Glenmede Trust sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 1,696 shares — an estimated $77K sold.
Glenmede Trust first reported a position in BEAT in Q3 2013 and held it in 18 quarters. The position peaked at $43.4M in Q2 2018. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.
- Glenmede Trust reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
- Glenmede Trust sold 1,696 BioTelemetry, Inc. shares in Q4 2020, an estimated $77K.
- Glenmede Trust first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 18 quarters.
- Glenmede Trust's BioTelemetry, Inc. position peaked at $43.4M in Q2 2018.
- 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.
Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.